scorecardresearch
Business Today
Subscribe
PMS Today US News India UPSTART Weather BT Shorts NRI Education Election
BT Golf BT Mindrush BT Best Banks
Clear all
Search

COMPANIES

No Data Found

NEWS

No Data Found
Sign in Subscribe
events
Special
  • BT tech today
  • BT 500 wealth creators summit
  • Economic Indicators
News
Markets
Stocks
Jenburkt Pharmaceuticals Ltd

Feedback
Jenburkt Pharmaceuticals Ltd

Jenburkt Pharmaceuticals Ltd Share Price

  • Sector: Pharmaceuticals (Small Cap)
  • Volume: 1,499
Mar 25, 2025 00:00 IST-
  • BSE
  • Share
    • Whatsapp
    • Twitter
    • Facebook
₹1,014.55
₹36.30 (3.71%)
    Powered By :
₹988.6 Low
Today’s Performance
₹1060 High
₹665 Low
52 Week’s Performance
₹1375 High

STOCK ANALYSIS

STOCK PERFORMANCE

  • 1 Day 3.71%
  • 1 Week 5.17%
  • 1 Month 1.57%
  • 3 Months -15.53%
  • 6 Months -9.21%
  • 1 Year 42.37%
  • 3 Years 23.72%
  • 5 Years 28.56%

PEER COMPARISON

STOCK SUMMARY

  • Face Value (₹) 10.00
  • Beta 1.10
  • 52-Week Low (₹) 665.00
  • 52-Week High (₹) 1,375.00
  • Price-to-Book (X)* 2.84
  • Dividend Yield (%) 1.51
  • Price-to-Earnings (P/E) (X)* 14.26
  • Earnings Per Share (₹) 71.16
  • Sector Price Earning (X)* 34.75
  • Market Cap (₹ Cr.)* 447.75
  • * Vaues as of last close price

COMPETITORS

BT TV

Siemens Transform Innovation Day - Episode 1 23:17 Siemens Transform Innovation Day - Episode 1
US Trade Delegation In India: Trump’s Reciprocal Tariffs Under Review? 3:42 US Trade Delegation In India: Trump’s Reciprocal Tariffs Under Review?
Budget 2025 Focuses On Growth, Tax Certainty & Reforms For Viksit Bharat: FM Sitharaman 2:55 Budget 2025 Focuses On Growth, Tax Certainty & Reforms For Viksit Bharat: FM Sitharaman
FM Clarifies: Tax Relief Ensures Minimal Tax For Incomes Slightly Above ₹12 Lakh 2:41 FM Clarifies: Tax Relief Ensures Minimal Tax For Incomes Slightly Above ₹12 Lakh
Big Update On 8th Pay Commission | FM Sitharaman Responds In Lok Sabha 4:02 Big Update On 8th Pay Commission | FM Sitharaman Responds In Lok Sabha
View more

FINANCIAL ANALYSIS

Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)
Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)

RATIO ANALYSIS

Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)
Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)

SHAREHOLDING PATTERN

Summary (as on 30 sep 2022)

DEALS

  • NSE
  • BSE

No Data For Block Deal.

*Single trade that involves transaction of a minimum quantity of 5 lakh shares or a minimum value of ₹ 10 crore.
Jan 06, 2023 PURCHASE
JENBURKT PHARMACEUTICALS LTD
  • Qty 47037
  • Average Price ₹649.97
Aug 25, 2020 Sell
ARIES STOCKTRADES PVT LTD A/C-PMS
  • Qty 26000
  • Average Price ₹410.39
Feb 08, 2018 Sell
TRUPTI KETAN KARANI
  • Qty 26000
  • Average Price ₹540.50
Feb 08, 2018 PURCHASE
KETAN JAYANTILAL KARANI (HUF)
  • Qty 26000
  • Average Price ₹540.50
Feb 08, 2018 PURCHASE
KETAN JAYANTILAL KARANI (HUF)
  • Qty 26000
  • Average Price ₹540.50
Feb 08, 2018 Sell
TRUPTI KETAN KARANI
  • Qty 26000
  • Average Price ₹540.50
Oct 24, 2017 PURCHASE
RAJASTHAN GLOBAL SECURITIES PRIVATE LIMITED
  • Qty 23887
  • Average Price ₹465.00
Oct 24, 2017 PURCHASE
RAJASTHAN GLOBAL SECURITIES PRIVATE LIMITED
  • Qty 23887
  • Average Price ₹465.00
Sep 05, 2017 Sell
GIRIK WEALTH ADVISORS PRIVATE LIMITED-DEEP VALUE PMS
  • Qty 30794
  • Average Price ₹433.26
Sep 05, 2017 Sell
GIRIK WEALTH ADVISORS PRIVATE LIMITED-DEEP VALUE PMS
  • Qty 30794
  • Average Price ₹433.26
*Involves transaction of at least 0.5% of the listed shares of a company.

FAQ’S

What was Jenburkt Pharmaceuticals Ltd share price previously?
Jenburkt Pharmaceuticals Ltd share price was up by 3.71% from the previous closing price of ₹978.25.
Who are peers of Jenburkt Pharmaceuticals Ltd?
The peers of Jenburkt Pharmaceuticals Ltd are Sun Pharmaceutical Industries Ltd, Divis Laboratories Ltd, Cipla Ltd, Torrent Pharmaceuticals Ltd, Mankind Pharma Ltd, Dr Reddys Laboratories Ltd, Lupin Ltd.
Who is/are the promoter/promoters of Jenburkt Pharmaceuticals Ltd?
The promotor/promotors of Jenburkt Pharmaceuticals Ltd are Ashish R Shah, Ashish U Bhuta, Dilip H Bhuta, Hina Ravindra Mehta, Sumit Ajaybhai Thakkar, KRISHNAN SUBHARAMAN, PANKAJ ..
What has been 52-week high of Jenburkt Pharmaceuticals Ltd stocks?
The highest price of Jenburkt Pharmaceuticals Ltd stock is ₹1,375.00 in the last 52-week.
What is the share price of Jenburkt Pharmaceuticals Ltd () today on BSE?
As on Mar 25, 2025, Jenburkt Pharmaceuticals Ltd ()’s share price on BSE is Rs 1014.55
What is the market cap of Jenburkt Pharmaceuticals Ltd (?)
The current market capitalisation of Jenburkt Pharmaceuticals Ltd () is 447.75 crores
What is Jenburkt Pharmaceuticals Ltd Share symbol?
The symbol of Jenburkt Pharmaceuticals Ltd is .
What is the PE ratio of Jenburkt Pharmaceuticals Ltd ()?
The current PE ratio of Jenburkt Pharmaceuticals Ltd () is 14.26.
What is the PB ratio of Jenburkt Pharmaceuticals Ltd ()?
The current PB ratio of Jenburkt Pharmaceuticals Ltd () is 2.84.
Today’s High & Low share prices of Jenburkt Pharmaceuticals Ltd () on BSE?
Today, the share price of Jenburkt Pharmaceuticals Ltd () on BSE touched a high of Rs 1060 and a low of Rs 988.6
What price did Jenburkt Pharmaceuticals Ltd () shares open on the BSE today?
On BSE, the share price of Jenburkt Pharmaceuticals Ltd () opened at Rs 988.6
What is the 52-week high of Jenburkt Pharmaceuticals Ltd ()?
The 52-week high price of Jenburkt Pharmaceuticals Ltd () is Rs 1375
What is the 52-week low of Jenburkt Pharmaceuticals Ltd () ?
The 52-week low price of Jenburkt Pharmaceuticals Ltd () is Rs 665

ABOUT JENBURKT PHARMA

Jenburkt Pharmaceuticals Ltd, incorporated in the year 1985, has its registered office in Nirmala Apartment P B No 37396, 93 Jayprakash Road Andheri(W), Mumbai, Maharashtra, 400058, 91-22-66943121/67603603, 91-22-66943127. The main industry in which Jenburkt Pharmaceuticals Ltd operates is Pharmaceuticals - Indian - Formulations.

Auditor/Auditors for Jenburkt Pharmaceuticals Ltd is/are D R Mehta & Associates. In the main management, Ashish U Bhuta is chairman and Ashish R Shah is the company secretary for Jenburkt Pharmaceuticals Ltd.

  • ARS Ashish R Shah Company Sec. & Compli. Officer
  • AUB Ashish U Bhuta Chairman & Managing Director
  • DHB Dilip H Bhuta Whole Time Director & CFO
  • HRM Hina Ravindra Mehta Non-Exec. & Independent Dir.
  • SAT Sumit Ajaybhai Thakkar Independent Director
  • KS KRISHNAN SUBHARAMAN Independent Director
  • P. PANKAJ . Independent Director

Top Stories

Thank you! Your transaction has been completed successfully.
Sorry! Transaction failed. Please try again later.

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.

Advertisement